N/A - Bile Esculin Agar / Sodium Chloride (NaCl) 6.5% - HARDY DIAGNOSTICS

Duns Number:039981550

Device Description: Bile Esculin Agar / Sodium Chloride (NaCl) 6.5% without Indicator, 15x100mm Biplate, 10ml/ Bile Esculin Agar / Sodium Chloride (NaCl) 6.5% without Indicator, 15x100mm Biplate, 10ml/10ml. Hardy Diagnostics Bile Esculin Agar (BEA) is recommended for use as a differential medium in the isolation and presumptive identification of enterococci/group D streptococci. Hardy Diagnostics NaCl 6.5% Media are recommended for use in salt tolerance testing to differentiate Enterococcus from non-enterococcal group D streptococci.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

J165

Brand Name

N/A

Version/Model Number

J165

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

JSI

Product Code Name

Culture Media, Selective And Differential

Device Record Status

Public Device Record Key

f9bed442-df38-4c78-8cd9-6a50a3590381

Public Version Date

May 28, 2020

Public Version Number

1

DI Record Publish Date

May 20, 2020

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"HARDY DIAGNOSTICS" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 630
2 A medical device with a moderate to high risk that requires special controls. 132